Cyendiv contains Nintedanib, an oral tyrosine kinase inhibitor used to treat idiopathic pulmonary fibrosis (IPF), non-small cell lung cancer (NSCLC), and systemic sclerosis-associated interstitial lung disease (SSc-ILD). Nintedanib works by targeting multiple kinases involved in the fibrosis process, slowing down the progression of lung disease and potentially improving overall lung function. It is typically used in combination with other therapies for its full effect.

• Reduces disease progression: Helps slow the decline in lung function in patients with idiopathic pulmonary fibrosis (IPF)

• Effective for lung diseases: Approved for use in the treatment of systemic sclerosis-associated interstitial lung disease (SSc-ILD)

• Non-small cell lung cancer treatment: Part of the treatment for NSCLC in combination with other chemotherapy agents

• Convenient oral form: Available in easy-to-take capsule form for daily administration

• Dosage: The recommended dose is 150 mg twice daily (morning and evening)

• Administration: Swallow the capsule whole with a glass of water. Do not crush or chew the capsule

• Meal: It can be taken with or without food

• Missed Dose: If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not take two doses at the same time to make up for a missed dose

• Duration: Treatment duration is determined by your doctor based on response and any side effects experienced

• Active Ingredient: Nintedanib (100 mg per capsule)

• Route of Administration: Oral (capsule)

• Recommended Dose: 150 mg twice daily, as prescribed by your healthcare provider

• Monitoring: Regular liver function tests are recommended during treatment

• Liver function: Nintedanib can cause liver problems, so regular liver enzyme tests are necessary

• Bleeding risk: Nintedanib can increase the risk of bleeding, especially in patients with underlying conditions or those on blood-thinning medications

• Pregnancy: Do not take Cyendiv during pregnancy. It may harm the fetus

• Drug interactions: Inform your doctor of any other medications, especially anticoagulants and anti-cancer drugs, as there may be interactions

• Gastrointestinal effects: Nintedanib may cause diarrhea, nausea, and abdominal pain; stay hydrated and contact your healthcare provider if these symptoms persist

• Common side effects: Diarrhea, nausea, vomiting, fatigue, and loss of appetite

• Serious side effects: Liver problems, bleeding issues, high blood pressure, lung infections, heart problems, and gastrointestinal perforations

• Seek medical help immediately if you experience severe abdominal pain, black stools, coughing up blood, or unusual bruising or bleeding.